在ANCA相关的血管炎中,对葡萄糖皮质类药物治疗的并发症和后果进行前性研究
Paul J Scherbacher1, Bernhard Hellmich1, You-Shan Feng2
1Department of Internal Medicine, Rheumatology, Pneumology, Nephrology and Diabetology, Medius Klinik Kirchheim/Teck, University of Tübingen, Kirchheim unter Teck, Germany.
RMD open
|March 1, 2024
概括
葡萄糖皮质类药物 (GC) 对抗中性粒细胞抗体相关的血管类药物 (AAV) 至关重要,但会引起毒性. 这项研究表明GC毒性是可测量的,并与累积剂量相关,支持减少AAV患者GC使用的努力.
科学领域:
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
背景情况:
- 葡萄糖皮质类药物 (GC) 对于治疗抗中性子细胞质抗体相关的血管类药物 (AAV) 非常重要.
- 然而,GC治疗与显著的发病率和死亡率有关.
- 对AAV中GC毒性的系统研究仍然有限.
研究的目的:
- 系统地调查与抗中性细胞质抗体相关的血管性抗体 (AAV) 患者的葡萄糖皮质激素 (GC) 毒性.
- 评估GC暴露,毒性和疾病活性之间的关系.
- 为了确定与增加毒性风险相关的GC剂量值.
主要方法:
- 一个单一的前性研究包括138名患有AAV的患者.
- 用结构化采访,临床检查和电子医疗记录来评估葡萄糖皮质激素毒性.
- 葡萄糖皮质激素毒性指数 (GTI),包括GTI-总体改善得分 (GTI-AIS) 和GTI-累积恶化得分 (GTI-CWS),在基线和6个月后进行评估.
主要成果:
- 在GC暴露和毒性之间发现了显著的相关性 (p<0.001).
- 与缓解相比,在活跃的AAV中观察到更高的GTI-AIS (p<0.001).
- 较高的GTI-CWS与长期疾病和高累积GC剂量 (p=0.003) 有关. 累计GC剂量≥935毫克预测了80%的有意义的GTI变化的可能性.
结论:
- 葡萄糖皮质醇毒性指数 (GTI) 有效地捕捉了AAV患者的GC毒性.
- GTI可以识别患有GC相关副作用风险较高的患者.
- 这些发现支持在AAV管理中尽量减少GC暴露的策略.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...


